Early Treatment Shown To Reduce Complication Risk For Crohn’s Disease Patients

Written for Mediaplanet’s Digestive Wellness campaign.

Crohn’s disease can be a debilitating condition, but recent Canadian research reveals that people living with this disease can be treated more effectively by using existing therapies in a new way.

The REACT (Randomized Evaluation of an Algorithm for Crohn’s Treatment) trial followed the treatment of nearly 2,000 Crohn’s patients in Canada and Belgium over the course of two years.“It’s simply using the tools we already have but in a more responsible way.”

“This is the largest study ever conducted on Crohn’s disease,” says Dr. Brian Feagan, Director of Robarts Clinical Trials at Western University and the lead author of the REACT study. He adds that the results indicate a need for change in how this disease is managed.

Read the full story here.

Advertisements